What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

about

Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review.

P2860

Q39420995-99E8D03D-1922-404B-95B1-A8923F943C99

P2860

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

Item

http://www.wikidata.org/entity/Q38839156

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

What causes a small increase i ...... ients tapering TNF inhibitors?

@en

type

Item

label

What causes a small increase i ...... ients tapering TNF inhibitors?

@en

prefLabel

What causes a small increase i ...... ients tapering TNF inhibitors?

@en

P1476

What causes a small increase i ...... ients tapering TNF inhibitors?

@en

P2093

Aatke van der Maas

http://www.w3.org/2001/XMLSchema#string

Chantal A M Bouman

http://www.w3.org/2001/XMLSchema#string

Frank H J van den Hoogen

http://www.w3.org/2001/XMLSchema#string

Noortje van Herwaarden

http://www.w3.org/2001/XMLSchema#string

Robert B M Landewé

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

How to read radiographs according to the Sharp/van der Heijde method.

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.

Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid Arthri

Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose.

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study.

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

P304

e000327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2016-000327

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alfons A den Broeder

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28405469

http://www.w3.org/2001/XMLSchema#string

P932

5372038

http://www.w3.org/2001/XMLSchema#string

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

about

P2860

P2860

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932